Flagship Pioneering, a VC fund run and majority owned by Moderna chairman and cofounder Noubar Afeyan, sold the shares in late February and late March.
In her first interview with a transgender journalist since being sworn-in as the nation’s new Assistant Secretary for Health, Dr. Rachel Levine discusses the Johnson & Johnson vaccine, the politicization of healthcare and anti-trans bills sweeping the …
Regulators in the EU and US meet this week to determine whether to resume administering the vaccine after reports of an extremely rare blood clotting side effect.